Skip to main content
. 2023 Dec 26;15(12):6928–6945. doi: 10.21037/jtd-23-1746

Figure 14.

Figure 14

TIDE scores for the low-risk and high-risk groups. ***, P<0.01. TIDE, tumor immune dysfunction and exclusion.